Idiopathic Thrombocytopenia Purpura After Pembrolizumab Treatment Against Locally Recurrent Bladder Cancer : A Case Report

Idiopathic Thrombocytopenia Purpura After Pembrolizumab Treatment Against Locally Recurrent Bladder Cancer : A Case Report

A man in his 70s visited our hospital for gross hematuria. He was diagnosed with invasive urothelial carcinoma (cT3N2M0) and underwent total cystectomy and ileum conduit construction after three courses of neoadjuvant chemotherapy. Eight months after the operation, the disease reoccurred in the pelv...

Full description

Saved in:
Bibliographic Details
Published in:Hinyokika kiyo. Acta urologica Japonica Vol. 69; no. 9; pp. 255 - 258
Main Authors: Hattori, Yuna, Kato, Manabu, Imamura, Tetsuya, Inaba, Souta, Terabe, Takashi, Kato, Momoko, Higashi, Shinichiro, Sasaki, Takeshi, Masui, Satoru, Yoshio, Yuko, Nishikawa, Kouhei, Uchida, Katsunori, Inoue, Takahiro
Format: Journal Article
Language:Japanese
Published: 01-09-2023
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:A man in his 70s visited our hospital for gross hematuria. He was diagnosed with invasive urothelial carcinoma (cT3N2M0) and underwent total cystectomy and ileum conduit construction after three courses of neoadjuvant chemotherapy. Eight months after the operation, the disease reoccurred in the pelvic lesion. He received pembrolizumab therapy but developed idiopathic thrombocytopenic purpura (ITP) immediately before the ninth course of administration; and, treatment was discontinued. Recovery of symptoms and normalization of blood test data were achieved 3.5months after starting steroid treatment. Reduction of recurrent disease has been maintained for 2 years.
Bibliography:ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
ISSN:0018-1994
DOI:10.14989/ActaUrolJap_69_9_255